HMGCR and breast carcinoma: While, in breast cancer, decreased intracellular cholesterol was related to metastatic behavior of advanced stage of tumor cells and low expression of SREBP2 and 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) evidently was associated with high EMT of the primary tumors 88.